{"id":"W2144984387","doi":"10.1016/s0140-6736(06)69154-x","title":"Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials","year":2006,"lang":"en","type":"article","venue":"The Lancet","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":323,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"International AIDS Society","keywords":"Ritonavir; Regimen; Medicine; Protease inhibitor (pharmacology); Internal medicine; Viral load; Randomized controlled trial; Pharmacology; Gastroenterology; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006325213,0.0003106139,0.00303394,0.0004153364,0.00006450728,0.00002306954,0.0005096174,0.00006045313,0.00001906178],"category_scores_gemma":[0.0003733578,0.0001637639,0.0001358538,0.001048925,0.0002464808,0.0003580815,0.00006427295,0.00007503577,2.52859e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003562107,"about_ca_system_score_gemma":0.00015147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005617565,"about_ca_topic_score_gemma":0.01004989,"domain_scores_codex":[0.9938919,0.002800686,0.001807047,0.0004792112,0.00077978,0.0002413651],"domain_scores_gemma":[0.9949906,0.00176338,0.001688255,0.0009935914,0.0005304697,0.00003367896],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7293165,0.01569096,0.2419517,0.0001024441,0.002545236,0.000002021052,0.00811934,0.0009178708,0.0008190846,0.00005941177,0.00002347646,0.0004519682],"study_design_scores_gemma":[0.7363588,0.001784939,0.2253653,0.0004696604,0.003910892,4.824608e-8,0.003054058,0.02801574,0.000827099,0.00007762309,5.503039e-7,0.0001352778],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897441,0.0001728982,0.00003303496,0.0001005601,0.00002243709,0.009340111,0.0005331952,0.000008136482,0.00004548027],"genre_scores_gemma":[0.9861572,0.00004295679,0.001444456,0.000005820301,0.000009216236,0.0005256859,0.01172375,0.0000210281,0.00006986273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02709787,"threshold_uncertainty_score":0.8492115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1782479061759761,"score_gpt":0.4109949463905229,"score_spread":0.2327470402145468,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}